Prasanta Pradhan

Dr Prasanta Kumar Pradhan is currently working as Professor in Nuclear medicine at Sanjay Gandhi Postgraduate Institute of medical sciences (SGPGIMS). He completed his medical school from VSS Medical college, Burla, Odisha in 1987 and subsequently done M.D in Biophysics from prestigious All India Institute of Medical Sciences(AIIMS),New Delhi in 1992.Subsequently,received his Diploma in radiation medicine from Radiation medicine centre, BARC, Mumbai in 1994 and Diplomate in National Board (DNB) in Nuclear medicine from National Board of Examinations, New Delhi in 1995. He is recipient of Common wealth fellowship in U.K in Nuclear cardiology in 2005 and best clinical paper award from Society of Nuclear medicine, India in 1997. He is a fellow of Asian Nuclear medicine Board (FANMB), member of many nuclear medicine societies in the world like, Society of Nuclear medicine and molecular imaging, USA, European Association of Nuclear medicine, Europe. He has published many international and national publications and also in editorial board and reviewer of many national and international journals. He is currently academic and technical expert to all Institutions of national importance like AIIMS, New Delhi, PGIMER, Chandigarh, JIPMER, Puducherry and Regional cancer centres. He is also a visiting faculty to many universities abroad like Emory university, USA, Ohio state university, USA and USM, Malaysia. His major interest is in utilization of radioisotopes treatment of noncancerous and cancerous disease conditions. He is also actively utilizing telemedicine technology in continued care of thyroid cancer and neuroendocrine tumor patients for consultation and follow up since last decade. Dr Pradhan has leadership role being past President of Society of nuclear medicine, India and currently senate member in Asian Regional Cooperative Council of Nuclear medicine (ARCCNM), Korea and his mission is educating the members in adapting to newer radioisotopic procedures for diagnosis with hybrid imaging with SPECT-CT, PET-CT and PET-MRI as well as receptor based radionuclide therapy through continued education among its members globally and physician and surgeons of our country for better standard of care for the patient. He intends to have national and international societal partnership in telemedicine for harmonization globally.